| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Microbiology (medical) | 41 / 147 | 72nd | Q2 |
| Immunology and Allergy | 71 / 234 | 69th | Q2 |
| Microbiology | 59 / 194 | 69th | Q2 |
| Immunology | 80 / 243 | 67th | Q2 |
Compare journals
Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Current Topics in Microbiology and Immunology
Current Topics in Microbiology and Immunology is Scopus-indexed (Q2, CiteScore 6.7). Published by Springer Science and Business Media Deutschland GmbH.
Checked against the index lists dated .
ISSN 0070-217XVerify ISSN ↗2196-9965Verify ISSN ↗
Publisher: Springer Science and Business Media Deutschland GmbH
Cost to publish: No APC data — check the publisher
Not listed in: Web of Science, DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Quick answers
Is Current Topics in Microbiology and Immunology indexed in Scopus?
Yes — actively indexed in Scopus, coverage 1967–present, best quartile Q2, CiteScore 6.7.
What quartile is Current Topics in Microbiology and Immunology in Scopus?
Current Topics in Microbiology and Immunology is Q2 in Microbiology (medical) (rank 41 of 147), Q2 in Immunology and Allergy (rank 71 of 234) and Q2 in Microbiology (rank 59 of 194), by CiteScore 2025. It is ranked in 4 subject areas in all.
What is the impact factor of Current Topics in Microbiology and Immunology?
Current Topics in Microbiology and Immunology is not in the Web of Science Core Collection (SCIE, SSCI, AHCI or ESCI), so Clarivate publishes no Journal Impact Factor for it. Its Scopus CiteScore is 6.7, quartile Q2, 72nd percentile. Any "impact factor" quoted elsewhere is not the Clarivate metric.
Who publishes Current Topics in Microbiology and Immunology and what is its ISSN?
Current Topics in Microbiology and Immunology is published by Springer Science and Business Media Deutschland GmbH. Its print ISSN is 0070-217X and its online ISSN is 2196-9965.
Is Current Topics in Microbiology and Immunology in Web of Science?
No — it is not currently in the Web of Science core collections (SCIE, SSCI, AHCI or ESCI).
Is Current Topics in Microbiology and Immunology open access?
No — it is not registered as an open-access journal in DOAJ or Scopus.
How well cited is Current Topics in Microbiology and Immunology? — open metrics via OpenAlex
Current Topics in Microbiology and Immunology has an h-index of 176 and a 2-year mean of 1.19 citations per paper (OpenAlex). Its Scopus CiteScore is 6.7, quartile Q2. On 2-year citations it ranks #103 of 144 Scopus journals in Microbiology (medical).
Current Topics in Microbiology and Immunology published 55 papers in 2025; its busiest recent year was 2017 with 122. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
Are there integrity warnings for Current Topics in Microbiology and Immunology? — indicators, not proof of misconduct
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
- Scopus statusActive
- Retracted papers None recorded
- Problematic Paper Screener flags None flagged
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Official sources & links
Community experience: reader comments on this journal
Related journals
8 journalsIndex data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.